Jun Gong

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 29

Top Topics

Metastatic Renal Cell Carcinoma

Top Venues

JCO precision oncology

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, Susan Percy Ivy, Victoria Wang, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2. JCO precision oncology 8 (2024)
Jun Gong, Jessica L Janes, Claire Trustram Eve, Shannon Stock, Justin Waller, Amanda M De Hoedt, Jeri Kim, Sameer R Ghate, Irene M Shui, Stephen J Freedland
Epidemiology, treatment patterns, and clinical outcomes in de novo oligometastatic hormone-sensitive prostate cancer. Cancer (2024)
Jeff Liang, Ryan Rastegar, Mohamad Othman El Helou, Kushagra Mathur, Brent K Larson, Kevin M Waters, Anila Rao Vasireddy, Navikran Randhawa, Muhammad Mubarak, Rashmi Advani, Arsen Osipov, Jun Gong, Andrew Hendifar, Quin Y Liu, Kenneth H Park, Rabindra Watson, Stephen Jacob Pandol, Simon Lo, Srinivas Gaddam
Incidence trends in upper GI cancer in young adults: a nationwide time-trend analysis using 2001-2019 United States Cancer Statistics databases. The American journal of gastroenterology (2024)
Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, Susan Percy Ivy, Victoria Wang, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1. JCO precision oncology 8 (2024)
Hayato Muranaka, Rasaq Akinsola, Sandrine Billet, Stephen Jacob Pandol, Andrew E Hendifar, Neil A Bhowmick, Jun Gong
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention. Cancers 16 (5) (2024)
Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, Susan Percy Ivy, Victoria Wang, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1. JCO precision oncology 8 (2024)
Yi Jiang, Yazan Abboud, Jeff Liang, Brent Larson, Arsen Osipov, Jun Gong, Andrew E Hendifar, Katelyn Atkins, Quin Y Liu, Nicholas N Nissen, Debiao Li, Stephen Jacob Pandol, Simon K Lo, Srinavas Gaddam
The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocrine Tumors: A Nationwide Time-Trend Analysis Using 2001-2018 United States Cancer Statistics Databases. Cancers 16 (5) (2024)
Yi Jiang, Yazan Abboud, Jeff Liang, Brent Larson, Arsen Osipov, Jun Gong, Andrew E Hendifar, Katelyn Atkins, Quin Y Liu, Nicholas N Nissen, Debiao Li, Stephen Jacob Pandol, Simon K Lo, Srinavas Gaddam
The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocrine Tumors: A Nationwide Time-Trend Analysis Using 2001-2018 United States Cancer Statistics Databases. Cancers 16 (5) (2024)
Hayato Muranaka, Rasaq Akinsola, Sandrine Billet, Stephen Jacob Pandol, Andrew E Hendifar, Neil A Bhowmick, Jun Gong
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention. Cancers 16 (5) (2024)
Alanna Burwell, Stephen J Freedland, Jun Gong
Reducing Racial Inequalities in Prostate Cancer Treatment: Healthcare Access Barriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (7) (2024)
Hayato Muranaka, Rasaq Akinsola, Sandrine Billet, Stephen Jacob Pandol, Andrew E Hendifar, Neil A Bhowmick, Jun Gong
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention. Cancers 16 (5) (2024)
Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, Susan Percy Ivy, Victoria Wang, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2. JCO precision oncology 8 (2024)
Mihir Bikhchandani, Farin Amersi, Andrew Hendifar, Alexandra Gangi, Arsen Osipov, Karen Zaghiyan, Katelyn Atkins, May Cho, Francesca Aguirre, Dennis J Hazelett, Rocio Alvarez, Lisa Zhou, Megan P Hitchins, Jun Gong
POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval. Genes 14 (5) (2023)
Janice Oh, Yazan Abboud, Miguel Burch, Jun Gong, Kevin Waters, Jenan Ghaith, Yi Jiang, Kenneth H Park, Quin Y Liu, Rabindra Watson, Simon K Lo, Srinavas Gaddam
Rising Incidence of Non-Cardia Gastric Cancer among Young Women in the United States, 2000-2018: A Time-Trend Analysis Using the USCS Database. Cancers 15 (8) (2023)
Janice Oh, Yazan Abboud, Miguel Burch, Jun Gong, Kevin Waters, Jenan Ghaith, Yi Jiang, Kenneth H Park, Quin Y Liu, Rabindra Watson, Simon K Lo, Srinavas Gaddam
Rising Incidence of Non-Cardia Gastric Cancer among Young Women in the United States, 2000-2018: A Time-Trend Analysis Using the USCS Database. Cancers 15 (8) (2023)
Jun Gong, Arsen Osipov, Jeremy Lorber, Mourad Tighiouart, Albert K Kwan, Hayato Muranaka, Rasaq Akinsola, Sandrine Billet, Abrahm Levi, Anser Abbas, John Davelaar, Neil Bhowmick, Andrew E Hendifar
Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol. Biomedicines 11 (5) (2023)
Sanjay Das, Nadine A Friedrich, James Percy Daniels, Gloria Cecilia Galván, Jun Gong, Edwin M Posadas, William J Aronson, Stephen J Freedland
Relative search popularity of five advanced prostate cancer medications using Google Trends. Prostate cancer and prostatic diseases (2023)
Jun Gong, Daniel M Kim, Amanda M De Hoedt, Neil A Bhowmick, Robert Figlin, Hyung Lae Kim, Howard M Sandler, Dan Theodorescu, Edwin M Posadas, Stephen J Freedland
Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hayato Muranaka, Andrew Hendifar, Arsen Osipov, Natalie Moshayedi, Veronica Placencio-Hickok, Nicholas Tatonetti, Aleksandr Stotland, Sarah Parker, Jennifer E Van Eyk, Stephen Jacob Pandol, Neil A Bhowmick, Jun Gong
Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. Cancers 15 (11) (2023)
Jun Gong, Daniel M Kim, Michael R Freeman, Hyung Kim, Leigh Ellis, Bethany Smith, Dan Theodorescu, Edwin Posadas, Robert Figlin, Neil Bhowmick, Stephen J Freedland
Genetic and biological drivers of prostate cancer disparities in Black men. Nature reviews. Urology (2023)
Jamil S Samaan, Yazan Abboud, Janice Oh, Yi Jiang, Rabindra Watson, Kenneth Park, Quin Liu, Katelyn Atkins, Andrew Hendifar, Jun Gong, Arsen Osipov, Debiao Li, Nicholas N Nissen, Stephen Jacob Pandol, Simon K Lo, Srinavas Gaddam
Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000-2018. Cancers 15 (3) (2023)
Jamil S Samaan, Yazan Abboud, Janice Oh, Yi Jiang, Rabindra Watson, Kenneth Park, Quin Liu, Katelyn Atkins, Andrew Hendifar, Jun Gong, Arsen Osipov, Debiao Li, Nicholas N Nissen, Stephen Jacob Pandol, Simon K Lo, Srinavas Gaddam
Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000-2018. Cancers 15 (3) (2023)
Jeremy Chuang, Samuel Klempner, Kevin Waters, Katelyn Atkins, Joseph Chao, May Cho, Andrew Hendifar, Alexandra Gangi, Miguel Burch, Pareen Mehta, Jun Gong
Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers. Diseases (Basel, Switzerland) 10 (2) (2022)
Jacob J Adashek, Joshua J Breunig, Edwin Posadas, Neil A Bhowmick, Leigh Ellis, Stephen J Freedland, Hyung Kim, Robert Figlin, Jun Gong
First-line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell Carcinoma: Where Are We Going, Where Have We Been? Drugs 82 (4) (2022)
Jun Gong, Andrew Hendifar, Alexandra Gangi, Karen Zaghiyan, Katelyn Atkins, Yosef Nasseri, Zuri Murrell, Jane C Figueiredo, Sarah Jeanne Salvy, Robert Haile, Megan Hitchins
Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer. Cancers 13 (18) (2021)
Eric M Anderson, Shant Thomassian, Jun Gong, Andrew Hendifar, Arsen Osipov
Advances in Pancreatic Ductal Adenocarcinoma Treatment. Cancers 13 (21) (2021)
Nicholas J Salgia, Alexander Chehrazi-Raffle, JoAnn Hsu, Zeynep Zengin, Sabrina Salgia, Neal S Chawla, Luis Meza, Jasnoor Malhotra, Nazli Dizman, Ramya Muddasani, Nora Ruel, Mary Cianfrocca, Jun Gong, Sidharth Anand, Victor Chiu, James Yeh, Sumanta Kumar Pal
Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California. Cancer medicine 10 (16) (2021)
Jun Gong, Michelle Guan, Christopher E Forsmark, Maria Q Petzel, Veronica Placencio-Hickok, Andrew Hendifar
Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma. Therapeutic advances in gastroenterology 13 (2020)
Haesoo Kim, Adrian J Jones, Artak Labadzhyan, Veronica R Placencio-Hickok, Daniel J Wallace, Jun Gong, Andrew E Hendifar
Raynaud's Phenomenon From PD-1 Immune Checkpoint Inhibition. JCO oncology practice 16 (10) (2019)